SCHEMBL4784564

SCHEMBL4784564

COC(=O)c1cccc2c1ccn2S(=O)(=O)c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.72
KMT2A Q03164 1/20 0.72
HTR6 P50406 14/20 0.64
HDAC3 O15379 1/20 0.57
HDAC4 P56524 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC7 Q8WUI4 1/20 0.57
HDAC2 Q92769 1/20 0.57
HDAC10 Q969S8 1/20 0.57
HDAC11 Q96DB2 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
HDAC9 Q9UKV0 1/20 0.57
HDAC5 Q9UQL6 1/20 0.57
FABP4 P15090 2/20 0.55
LMNA P02545 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
PLK1 P53350 1/20 0.54
HTR1A P08908 3/20 0.51
HTR1D P28221 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10708955 0.90 MEN1 (0.58) MEN1KMT2AHTR6HDAC3HDAC4
SCHEMBL27849149 0.85 HTR6 (0.68) MEN1KMT2AHTR6HDAC3HDAC4
SCHEMBL2886421 0.84 KMT2A (1.00) MEN1KMT2AHTR6LMNASMN1; SMN2
SCHEMBL4023835 0.83 HTR6 (0.67) MEN1KMT2AHTR6HDAC3HDAC4
SCHEMBL7465227 0.83 HTR6 (0.54) MEN1KMT2AHTR6FABP4
SCHEMBL18824171 0.83 MEN1 (0.59) MEN1KMT2AHTR6HDAC3HDAC4
SCHEMBL12748307 0.80 FABP4 (0.62) MEN1KMT2AHTR6FABP4
SCHEMBL4022039 0.79 HTR6 (0.60) MEN1KMT2AHTR6HDAC3HDAC4
SCHEMBL5998210 0.79 MEN1 (0.54) MEN1KMT2AHTR6HDAC3HDAC4
SCHEMBL7424793 0.78 MAPT (0.48) MEN1KMT2AHTR6FABP4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008060998-A1 INDOLE SULFONAMIDES AS SFRP-1 MODULATORS WYETH (US) 2008-05-22 WO disclosed
WO-2008060998-A1 INDOLE SULFONAMIDES AS SFRP-1 MODULATORS WYETH (US) 2008-05-22 WO disclosed
US-6187805-B1 TREATING CONDITION FOR WHICH SELECTIVE AGONISM OR ANTAGONISM OF 5-HT-6 RECEPTORS IS INDICATED BY ADMINISTERING COMPOUNDS SUCH AS N,N-DIMETHYL 2-(1-(BENZENESULPHONYL)-5-METHOXY-1H-INDOL-3-YL)ETHYLAMINE MERCK SHARP & DOHME LTD. (GB) 2001-02-13 US disclosed
US-5545744-A Cyano naphthalene compounds AGOURON PHARMACEUTICALS, INC. (US) 1996-08-13 US disclosed
US-5498727-A Preparation of benzindole compounds from naphthalene compounds AGOURON PHARMACEUTICALS, INC. (US) 1996-03-12 US disclosed
WO-1996002502-A1 PREPARATION OF BENZINDOLE COMPOUNDS FROM NAPHTHALENE COMPOUNDS AGOURON PHARMACEUTICALS, INC. (US) 1996-02-01 WO disclosed